Trial · NCT07309601
Sucrase-Isomaltase (SI) Genes and Meal Load
The goal of this interventional study is to examine whether those patients with irritable bowel syndrome (IBS) and a reduced abitility do degrade starch and sug
- Status
- Recruiting
- Sponsor
- Region Skane
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 70 participants (planned)
- Start
- Feb 1, 2026
- Primary completion
- Feb 1, 2028
- Conditions
- IBS - Irritable Bowel Syndrome, Sucrase-Isomaltase Deficiency
Summary
The goal of this interventional study is to examine whether those patients with irritable bowel syndrome (IBS) and a reduced abitility do degrade starch and sugar (lowe levels of enzymes) have lower raise in blood glucose after a meal than those with normal expression of enzymes. We also want to examine whether those IBS patients with reduced enzyme levels have increased bowel symptom in relation to this meal. The main questions it aims to answer are: Does reduced ability to degrade starch and sugar due to less enzyme activity lead to lower increase in blood glucose after a meal?
Interventions
- Meal load Dietary supplement
Locations
1 country: Sweden.
| Facility | City | Country |
|---|---|---|
| Skåne University Hospital | Malmö, Skåne County | Sweden |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.